CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-08). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2477 · Search date 2026-08-08 · Methodology v0.7

Luminous doorframe night lighting,
does it really help with Reduced nighttime falls among assisted-living residents with dementia?

30-Second Summary
D
Evidence Grade D · 34 · Safety acceptable
Falls were fewer during doorframe-lighting nights, but the small crossover feasibility study was inconclusive
No serious direct harm was reported. Some families and staff mentioned brightness, color, or difficulty falling asleep, and poor installation could create wiring or attachment hazards.
What the
research shows
The grade is D with 34 points. In a 38-person randomized crossover feasibility trial, camera-confirmed falls numbered 31 over 3,604 lighting nights and 61 over 4,271 standard-nightlight nights. The period-adjusted incidence-density ratio was 0.66 (95% CI 0.35 to 1.22; P=0.18), allowing both a large reduction and an increase. The small, early-stopped study was strongly influenced by one resident with 34 falls.
What the
ads claim
This was not a generic motion-sensor lamp. The system placed 68 amber LEDs above and 140 on each side of the bathroom or entry doorframe, continuously operating from 7 pm to 7 am at no more than 0.5 lux at the cornea from two meters, with glare shields. No bundled fall-prevention program was reported.
*

Useful facts when choosing a product

  • Control rooms used one standard 0.5-watt, 2700-K LED nightlight in the bedroom and one in the bathroom.
  • All three sides operated throughout the night on only 75.4% of recorded lighting nights.
  • The original Funding sources text states: “This work was supported by the National Institute on Aging (Grant R21AG059111).”
Gap Measurement · Verdict 2477 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Residents were assigned to one of four sequences, `CCLL`, `CLLC`, `LCCL`, or `LLCC`, across planned 90-day periods. No washout was reported. Illumination has little biological persistence after switch-off, but behavior after a fall and progressive frailty can carry across periods. The model included period effects, but a separate calendar-season analysis was not reported. Researchers reviewed infrared video recorded from 7 pm to 7 am; a more detailed operational fall definition could not be confirmed in the accessible text.

02

Why this is classified as D (34)

A publicly funded crossover trial measured real falls, but its very small sample, attrition, early stopping, and wide interval give D with 34 points.

Counterpoint. Verdict 2310 is D with 34 points for hospital bed-exit alarms, verdict 2449 is C with 56 points for hospital nonslip socks, and verdict 2450 is C with 56 points for barefoot or sock-only mobility. Their interventions and settings differ from fixed low-level doorframe lighting in dementia care.

Rejudgment record. Cross-check applied — Real fall events but a very wide interval in a 38-person feasibility study with attrition and early stopping

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduction in nighttime falls among assisted-living residents with dementiaDThe point estimate favored fewer falls, but the 95% confidence interval included 1.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized crossover feasibility trial in assisted living7,875Original wording: “This work was supported by the National Institute on Aging (Grant R21AG059111).”Falls confirmed on infrared video from 7 pm to 7 am31 falls over 3,604 nights versus 61 over 4,271; adjusted incidence-density ratio 0.66 (95% CI 0.35-1.22), P=0.18Exploratory single trial
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-08).

Zimmerman S, Sloane PD, et al. Feasibility of A Novel Lighting System to Reduce Nighttime Falls in Assisted Living Residents with Dementia. J Am Med Dir Assoc. 2024;25(10):105227. PMID: 39182511. PMCID: PMC11486553. DOI: 10.1016/j.jamda.2024.105227.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-08 · Corrections: none

Cite this verdict

Luminous doorframe night lighting x nighttime falls in dementia care Evidence Grade D card
[Chamgap] Luminous doorframe night lighting x nighttime falls in dementia care — Evidence Grade D·34. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/luminous-doorframe-night-light-dementia-falls/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.